Cloud Banner

Healthcare

Image

Global Drug Delivery Devices Market – Industry Trends and Forecast to 2030

  • Healthcare
  • Upcoming Report
  • Oct 2023
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Drug Delivery Devices Market, By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others) – Industry Trends and Forecast to 2030.

Drug Delivery Devices Market

Drug Delivery Devices Market Analysis and Size

The technological advancements in the medical device manufacturing has led to the development of innovative drug delivery devices that ensures right amount of medicine is administered to the patient at the right time. Moreover, the rising burden of chronic diseases such as diabetes, CVDs, cancer, and COPD is fuelling the demand for the drug delivery devices. According to the International Agency for Research on Cancer, in 2020, around 19.3 million new cancer cases and 10 million cancer deaths were reported across the globe. The global cancer cases are estimated to grow by 47% from 2020 to 2040. It is expected that 28.4 million cases will be recorded in 2040, globally. Moreover, the CVD accounted for around 32% of the global deaths in 2019. The rapid growth of the biopharmaceuticals and development of various drugs that can cure the chronic diseases efficiently fostered the demand for the drug delivery devices across the globe.

Moreover, the rise in the number of research and development activities associated will provide beneficial opportunities for the drug delivery devices market growth. The presence of several top players and the developmental strategies like acquisitions, mergers, collaborations, and new product launches augments the market growth. Furthermore, the increasing investments in the marketing activities by the market players positively impact the market growth.

Data Bridge Market Research analyses that the drug delivery devices market which was USD 2, 209.82 million in 2022, and would rocket up to USD 7,621.44 million by 2030, and is expected to undergo a CAGR of 17.6% during the forecast period. This indicates that the market value. “Hospital” dominates the patient care setting segment of the drug delivery devices market owing to the wide range of products applications there. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Drug Delivery Devices Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery), Patient Care Setting (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others), Application (Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

BD. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Antares Pharma (U.S.), Novartis AG (Switzerland), 3M (U.S.), Sulzer Ltd (Switzerland), Gerresheimer AG (Germany), Sanofi (France), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), GlaxoSmithKline plc (U.K.), Novosanis (Belgium), MEDMIX SYSTEMS AG (Switzerland), Merck & Co., Inc. (Germany), Pfizer Inc. (U.S.), Insulet Corporation (U.S.), OraSure Technologies, Inc. (U.S.), Enable Injections (U.S.), West Pharmaceutical Services, Inc. (U.S.), SMC Ltd. (Philippines), ViVO Smart Medical Devices Ltd. (U.K.), among others

Market Opportunities

  • Growing research and development activities
  • Increasing global healthcare expenditure

Market Definition

Drug delivery devices are the medical devices that are used to deliver the drugs in the body of patients with an aim to immune the body against infections and disease cells in the body. The drug delivery devices are used for numerous medical treatments and provide a therapeutic relief to the patients.

Global Drug Delivery Devices Market Dynamics

Drivers

  • Rising Prevalence of Diseases

Surging prevalence of acute and chronic diseases and infections all around the globe is one of the major factors responsible for fostering growth in the market value. According to a recent report, there are more than 20 million in the country suffering from diabetes and this number is projected to surpass 57 million by 2025.  This will further expand drive the market and lead to the growth of the drug delivery devices market in the above mentioned projected timeframe.

  • Research and Development Proficiencies

Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted over live viruses with an aim to develop drugs is also bolstering the market growth rate.

  • Government Investments on Healthcare Infrastructure

The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Moreover, growing initiatives by the government to provide the best of drugs against cancer, infectious diseases, respiratory diseases, diabetes, cardiovascular diseases and others in the remote areas will further carve the way for the growth.  

Opportunity

  • Increasing Public-Private Funding for Target Research Activities

The upsurge in the public-private funding for target research activities, increasing levels of air pollution, and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2023 to 2030. In addition, surging number of strategic collaborations, rising internet penetration rate, growing number of hospitals and laboratories, and increasing per capita expenditure on health care will further expand the market's growth rate in the future. This will extend profitable opportunities for the market players in the forecast period of 2023 to 2030.

In addition, surge in the personal disposable income level, introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices and rising number of cancers, respiratory diseases, and diabetic patients in the backward economies, positively affect the market growth rate.

Restraint/Challenge

  • High Cost Associated with the Research and Development Proficiencies

On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and imposition of stringent regulations on drug delivery systems are expected to obstruct market growth. Also, lack of favorable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2023 to 2030

This drug delivery devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In January 2021, Novartis AG made its investment in Credence MedSystems to support the development and scale-up of its drug delivery systems. This initiative facilitates Novartis AG to employ the Credence technology in its injectable medicines.
  • In November 2020, Croda International PLC entered an agreement with Pfizer Inc. to supply innovative drug delivery systems for Pfizer's COVID-19 Vaccine Candidate.

Global Drug Delivery Devices Market Scope

The drug delivery devices market is segmented on the basis of route of administration, patient care setting and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Route of Administration

  • Oral Drug Delivery
  • Injectable Drug Delivery
  • Topical Drug Delivery
  • Ocular Drug Delivery
  • Pulmonary Drug Delivery
  • Nasal Drug Delivery
  • Transmucosal Drug Delivery
  • Implantable Drug Delivery

Patient Care Setting

  • Hospitals
  • Diagnostic Centers
  • Ambulatory Surgery Centers/Clinics
  • Home Care Settings
  • Others

 Application

  • Cancer
  • Infectious Diseases
  • Respiratory Diseases
  • Diabetes
  • Cardiovascular Diseases
  • Autoimmune Diseases
  • Central Nervous System Disorders
  • Others

Global Drug Delivery Devices Market Regional Analysis/Insights

The drug delivery devices market is analysed and market size insights and trends are provided by route of administration, patient care setting and application as referenced above.

The countries covered in the drug delivery devices market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the drug delivery devices market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, growing number of processes pertaining to drug development, rising prevalence of chronic diseases, the presence of a large number of pharmaceutical companies and rising number of research activities in this region.  

Asia-Pacific is expected to witness significant growth during the forecast period due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, increasing incidences of chronic diseases for instance cardiovascular diseases, diabetes, cancer and other diseases and the growing demand for quality healthcare in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and up-stream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

The drug delivery devices market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for biomaterials market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the biomaterials market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Drug Delivery Devices Market Share Analysis

The drug delivery devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the company's focus related to drug delivery devices market.

Some of the major players operating in the drug delivery devices market are:

  • BD. (U.S.)
  • F. Hoffmann-La Roche Ltd (Switzerland)
  • Antares Pharma (U.S.)
  • Novartis AG (Switzerland)
  • 3M (U.S.)
  • Sulzer Ltd (Switzerland)
  • Gerresheimer AG (Germany)
  • Sanofi (France)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Bayer AG (Germany)
  • GlaxoSmithKline plc (U.K.)
  • Novosanis (Belgium)
  • MEDMIX SYSTEMS AG (Switzerland)
  • Merck & Co., Inc. (Germany)
  • Pfizer Inc. (U.S.)
  • Insulet Corporation (U.S.)
  • OraSure Technologies, Inc. (U.S.)
  • Enable Injections (U.S.)
  • West Pharmaceutical Services, Inc. (U.S.)
  • SMC Ltd. (Philippines)
  • ViVO Smart Medical Devices Ltd. (U.K.)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The drug delivery devices market size will be worth USD 7,621.44 million by 2030.
The growth rate of the drug delivery devices market is 17.6% in the forecast period by 2030.
The surging prevalence of acute and chronic diseases, rising expenditure for research and development proficiencies & government investments in healthcare infrastructure are the growth drivers of the drug delivery devices market.
Administration, patient care setting and application are the factors on which the drug delivery devices market research is based.
Major companies in the sulfate of drug delivery devices market are BD. (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Antares Pharma (U.S.), Novartis AG (Switzerland), 3M (U.S.), Sulzer Ltd (Switzerland), Gerresheimer AG (Germany), Sanofi (France), Johnson & Johnson Services, Inc. (U.S.), Bayer AG (Germany), GlaxoSmithKline plc (U.K.), Novosanis (Belgium), MEDMIX SYSTEMS AG (Switzerland), Merck & Co., Inc. (Germany), Pfizer Inc. (U.S.), Insulet Corporation (U.S.), OraSure Technologies, Inc. (U.S.), Enable Injections (U.S.), West Pharmaceutical Services, Inc. (U.S.), SMC Ltd. (Philippines), ViVO Smart Medical Devices Ltd. (U.K.), among others
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials